As issues of product consistency, standardization and specificity are being tackled, can phage therapeutics—long oversold and overhyped—finally realize their antibacterial potential?
Ambitious efforts to catalog viruses across the globe may facilitate our understanding of viral communities and ecology, boost infectious disease diagnostics and surveillance, and spur new therapeutics.
New initiatives aim to lessen the obstacles to finding useful treatments for children
In April, the US Food and Drug Administration cleared the first deuterated drug, Austedo (deutetrabenazine), from Teva of Petach Tikva, Israel, for the treatment of Huntington’sdisease-related movement disorders.
New U.S. law will require pediatric cancer clinic trials.
In May, the U.S. Preventive Services Task Force recommended against screening for thyroid cancer. After reviewing the available evidence, the task force concluded…